Feature Channels: Stem Cells

Filters close
Newswise: 1920_abu-dhabi-skyline-cedars-sinai.jpg?10000
Released: 7-May-2024 9:05 PM EDT
Cedars-Sinai to Join Abu Dhabi Global Healthcare Week
Cedars-Sinai

Cedars-Sinai experts are participating in the inaugural Abu Dhabi Global Healthcare Week, May 13-15 in Abu Dhabi, United Arab Emirates, highlighting their dedication to enhancing innovation and medical advances that will have a positive impact on communities worldwide.

Released: 7-May-2024 4:05 PM EDT
Yale Cancer Center Earns International Reaccreditation for Expertise in CAR T-cell Therapy and Stem Cell Transplantation
Yale Cancer Center/Smilow Cancer Hospital

Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH) have again received an internationally recognized accreditation for cellular therapy and stem cell transplantation from the Foundation for the Accreditation of Cellular Therapy (FACT), giving patients life-saving cancer treatment options in Connecticut.

Newswise: Researchers Find Key Signal Regulating Earliest Stages of Mammalian Development
Released: 7-May-2024 12:05 PM EDT
Researchers Find Key Signal Regulating Earliest Stages of Mammalian Development
University of Utah Health

The discovery opens doors to better stem cell therapies.

Released: 1-May-2024 11:05 AM EDT
UMSOM Preclinical Study Finds Novel Stem Cell Therapy Boosts Neural Repair After Cardiac Arrest
University of Maryland School of Medicine

New stem cell therapy in animal model could eventually lead to viable treatment option  Researchers at the University of Maryland School of Medicine (UMSOM) have identified an innovation in stem cell therapy to regenerate neural cells in the brain after cardiac arrest in an animal model. 

29-Apr-2024 11:05 AM EDT
Study: Hillocks challenge our understanding of lung biology
Tufts University

A research team from Tufts University School of Medicine and Massachusetts General Hospital is now reporting evidence that hillocks and their stem cells are physiologically distinct from other cells within the lung and consist of a stratified outer layer of scale-like squamous cells that protect an underlying layer of rapidly expanding basal stem cells that are capable of restoring airway tissue after injury.

Released: 26-Apr-2024 12:00 PM EDT
Interplay between mesenchymal stem cells and macrophages: Promoting bone tissue repair
World Journal of Stem Cells

The repair of bone tissue damage is a complex process that is well-orchestrated in time and space, a focus and difficulty in orthopedic treatment. In recent years, the success of mesenchymal stem cells (MSCs)-mediated bone repair in clinica

Released: 26-Apr-2024 12:00 PM EDT
Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19
World Journal of Stem Cells

Coronavirus disease 2019 (COVID-19) is an acute respiratory infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 infection typically presents with fever and respiratory symptoms, which can progress to

Released: 26-Apr-2024 12:00 PM EDT
Biological scaffold as potential platforms for stem cells: Current development and applications in wound healing
World Journal of Stem Cells

Wound repair is a complex challenge for both clinical practitioners and researchers. Conventional approaches for wound repair have several limitations. Stem cell-based therapy has emerged as a novel strategy to address this issue, exhibitin

Released: 26-Apr-2024 12:00 PM EDT
Effects of high glucose and severe hypoxia on the biological behavior of mesenchymal stem cells at various passages
World Journal of Stem Cells

BACKGROUNDMesenchymal stem cells (MSCs) have been extensively studied for therapeutic potential, due to their regenerative and immunomodulatory properties. Serial passage and stress factors may affect the biological characteristics of MSCs,

Released: 26-Apr-2024 12:00 PM EDT
Gossypol acetic acid regulates leukemia stem cells by degrading LRPPRC via inhibiting IL-6/JAK1/STAT3 signaling or resulting mitochondrial dysfunction
World Journal of Stem Cells

BACKGROUNDLeukemia stem cells (LSCs) are found to be one of the main factors contributing to poor therapeutic effects in acute myeloid leukemia (AML), as they are protected by the bone marrow microenvironment (BMM) against conventional ther

Released: 26-Apr-2024 12:00 PM EDT
Expansion of human umbilical cord derived mesenchymal stem cells in regenerative medicine
World Journal of Stem Cells

BACKGROUNDStem cells are undifferentiated cells that possess the potential for self-renewal with the capacity to differentiate into multiple lineages. In humans, their limited numbers pose a challenge in fulfilling the necessary demands for

Released: 26-Apr-2024 12:00 PM EDT
Reveal more mechanisms of precondition mesenchymal stem cells inhibiting inflammation
World Journal of Stem Cells

Hypoxia can get more ability to inhibit inflammation. But how it impact on survival time of mesenchymal stem cells (MSCs) is confusing and how preconditioned MSCs inhibiting inflammation are partially known. Those issues decided the value o

Released: 26-Apr-2024 12:00 PM EDT
Unveiling the role of hypoxia-inducible factor 2alpha in osteoporosis: Implications for bone health
World Journal of Stem Cells

BACKGROUNDOsteoporosis (OP) has become a major public health problem worldwide. Most OP treatments are based on the inhibition of bone resorption, and it is necessary to identify additional treatments aimed at enhancing osteogenesis. In the

Released: 26-Apr-2024 12:00 PM EDT
Adipose-derived regenerative therapies for the treatment of knee osteoarthritis
World Journal of Stem Cells

Knee osteoarthritis is a degenerative condition with a significant disease burden and no disease-modifying therapy. Definitive treatment ultimately requires joint replacement. Therapies capable of regenerating cartilage could significantly

Newswise: Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital's Transplant and Cell Therapy
Released: 25-Apr-2024 10:05 AM EDT
Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital's Transplant and Cell Therapy
Rutgers Cancer Institute of New Jersey

The Foundation for the Accreditation of Cellular Therapy (FACT) has once again awarded Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital’s (RWJUH) Transplant and Cell Therapy Program accreditation under the FACT-JACIE International Standards for Hematopoietic Cellular Therapy

Newswise: Unlocking the ‘chain of worms’
Released: 15-Apr-2024 9:05 AM EDT
Unlocking the ‘chain of worms’
Washington University in St. Louis

Biologist B. Duygu Özpolat at Washington University in St. Louis and colleagues published a single-cell atlas for a highly regenerative annelid worm. This research may help inform stem cell technologies and regenerative medicine down the line.

Newswise: AACR: Novel immunotherapies show promise for patients with kidney cancer and for solid organ transplant recipients with skin cancer
4-Apr-2024 3:00 PM EDT
AACR: Novel immunotherapies show promise for patients with kidney cancer and for solid organ transplant recipients with skin cancer
University of Texas MD Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center presented encouraging findings today from two clinical trials in a plenary session highlighting advances in novel immunotherapy approaches at the American Association for Cancer Research (AACR) Annual Meeting 2024.

   
Released: 4-Apr-2024 3:05 PM EDT
Novel Biological Mechanism Discovered That Could Lead to New Treatments for Neurological Disorders, Cancers
Ann and Robert H. Lurie Children's Hospital of Chicago

The lab of Yongchao C. Ma, PhD, at Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago discovered a fundamental biological mechanism that could lead to new treatments for neurological diseases, such as spinal muscular atrophy (SMA) and autism, as well as different cancers.

Released: 1-Apr-2024 2:05 PM EDT
Mayo Clinic scientists pioneer immunotherapy technique for autoimmune diseases
Mayo Clinic

Mayo Clinic scientists have developed an immunotherapy strategy that potentially lays the groundwork for treating a spectrum of autoimmune diseases. 

Not for public release

This news release is embargoed until 1-Apr-2024 5:00 AM EDT Released to reporters: 28-Mar-2024 8:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-Apr-2024 5:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Andrew E. Place, MD, PhD appointed as Dana-Farber/Boston Children’s Cancer and Blood Disorders Center Vice President, Pediatric Chief Medical Officer
Released: 28-Mar-2024 9:00 AM EDT
Andrew E. Place, MD, PhD appointed as Dana-Farber/Boston Children’s Cancer and Blood Disorders Center Vice President, Pediatric Chief Medical Officer
Dana-Farber Cancer Institute

Andrew E. Place, MD, PhD, has been named as Vice President, Pediatric Chief Medical Officer (CMO) at Dana-Farber Cancer Institute (within the Department of Pediatric Oncology) and Boston Children’s Hospital (within the Division of Hematology/Oncology) for the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.

Released: 27-Mar-2024 10:05 AM EDT
Study of Different Autism Types Finds Shared Mechanism That May Respond to Drugs
Rutgers University-New Brunswick

Rutgers Health researchers detect similar disruptions in the neural development of genetic and unexplained autism.

Newswise: Researcher’s microscale tech is chipping away at cancer, organ failure and neurological disease
Released: 26-Mar-2024 3:05 PM EDT
Researcher’s microscale tech is chipping away at cancer, organ failure and neurological disease
Arizona State University (ASU)

For outstanding contributions to engineering of biomimetic tissue-on-chip technologies and organoids for disease modeling and regenerative medicine, ASU's Mehdi Nikkhah has been inducted as a Fellow into the American Institute for Medical and Biomedical Engineering.

Released: 26-Mar-2024 12:00 PM EDT
Low-intensity pulsed ultrasound reduces alveolar bone resorption during orthodontic treatment via Lamin A/C-Yes-associated protein axis in stem cells
World Journal of Stem Cells

BACKGROUNDThe bone remodeling during orthodontic treatment for malocclusion often requires a long duration of around two to three years, which also may lead to some complications such as alveolar bone resorption or tooth root resorption. Lo

Released: 26-Mar-2024 12:00 PM EDT
O-linked β-N-acetylglucosaminylation may be a key regulatory factor in promoting osteogenic differentiation of bone marrow mesenchymal stromal cells
World Journal of Stem Cells

Cumulative evidence suggests that O-linked β-N-acetylglucosaminylation (O-GlcNAcylation) plays an important regulatory role in pathophysiological processes. Although the regulatory mechanisms of O-GlcNAcylation in tumors have been graduall

Released: 26-Mar-2024 12:00 PM EDT
Evaluation of genetic response of mesenchymal stem cells to nanosecond pulsed electric fields by whole transcriptome sequencing
World Journal of Stem Cells

BACKGROUNDMesenchymal stem cells (MSCs) modulated by various exogenous signals have been applied extensively in regenerative medicine research. Notably, nanosecond pulsed electric fields (nsPEFs), characterized by short duration and high st

Released: 26-Mar-2024 12:00 PM EDT
Long-term outcome of stem cell transplantation with and without anti-tumor necrotic factor therapy in perianal fistula with Crohn’s disease
World Journal of Stem Cells

BACKGROUNDStem cell transplantation is a promising therapeutic option for curing perianal fistula in Crohn’s disease (CD). Anti-tumor necrotic factor (TNF) therapy combined with drainage procedure is effective as well. However, previous s

Released: 26-Mar-2024 12:00 PM EDT
Understanding host-graft crosstalk for predicting the outcome of stem cell transplantation
World Journal of Stem Cells

Mesenchymal stromal cells (MSCs) hold great promise for tissue regeneration in debilitating disorders. Despite reported improvements, the short-term outcomes of MSC transplantation, which is possibly linked to poor cell survival, demand ext

Released: 26-Mar-2024 12:00 PM EDT
Self-assembly of differentiated dental pulp stem cells facilitates spheroid human dental organoid formation and prevascularization
World Journal of Stem Cells

BACKGROUNDThe self-assembly of solid organs from stem cells has the potential to greatly expand the applicability of regenerative medicine. Stem cells can self-organise into microsized organ units, partially modelling tissue function and re

Released: 26-Mar-2024 12:00 PM EDT
How mesenchymal stem cells transform into adipocytes: Overview of the current understanding of adipogenic differentiation
World Journal of Stem Cells

Mesenchymal stem cells (MSCs) are stem/progenitor cells capable of self-renewal and differentiation into osteoblasts, chondrocytes and adipocytes. The transformation of multipotent MSCs to adipocytes mainly involves two subsequent steps fro

Released: 26-Mar-2024 12:00 PM EDT
High glucose microenvironment and human mesenchymal stem cell behavior
World Journal of Stem Cells

High glucose (HG) culture conditions in vitro and persistent exposure to hyperglycemia in diabetes patients are detrimental to stem cells, analogous to any other cell type in our body. It interferes with diverse signaling pathways, i.e. mam

Released: 25-Mar-2024 11:05 AM EDT
AACR: Progress treating pancreatic cancer, immunotherapy for head and neck cancers, potential biomarker for aggressive neuroendocrine carcinomas and more
University of California, Los Angeles (UCLA), Health Sciences

The annual meeting will feature more than 40 regular, late-breaking and clinical trial abstracts from UCLA physicians and scientists, who will present their latest work in key areas of translational and basic scientific research, including new compounds and drug targets, combination immunotherapy approaches, updated organoid models, survivorship research and more.

Newswise: All creatures great and small: Sequencing the blue whale and Etruscan shrew genomes
Released: 18-Mar-2024 5:05 PM EDT
All creatures great and small: Sequencing the blue whale and Etruscan shrew genomes
University of Wisconsin–Madison

The blue whale genome was published in the journal Molecular Biology and Evolution, and the Etruscan shrew genome was published in the journal Scientific Data.

Newswise: Breakthrough Discovery: Stem Cell
Released: 18-Mar-2024 8:05 AM EDT
Breakthrough Discovery: Stem Cell "Messages" Fast-Track Healing of Diabetic Wounds
Chinese Academy of Sciences

A study has unveiled that exosomes, extracted from adipose mesenchymal stem cells (ADSC-Exos), markedly speed up the healing process of skin wounds in diabetic mice. This discovery tackles the pressing global health issue of diabetic wounds, notorious for precipitating grave complications and impairments.

Newswise: Modulation of cellular recycling by calcium ion dynamics across cellular compartments
Released: 12-Mar-2024 8:05 AM EDT
Modulation of cellular recycling by calcium ion dynamics across cellular compartments
Chinese Academy of Sciences

This study discovers that upon induction of different autophagy processes, mitochondria immediately import calcium and calcium concentrations at the ER membrane start to fluctuate. The major calcium import channel in the inner mitochondrial membrane, mitochondrial calcium uniporter (MCU), is required for mitophagy-inducer-initiated mitochondrial calcium uptake. Inhibiting MCU accelerates mitophagy. In neurons derived from a Parkinson’s patient, mitophagy-inducer-triggered mitochondrial calcium influx is faster, which may slow the ensuing mitophagy.

Newswise: Iron Restriction Keeps Blood Stem Cells Young
Released: 8-Mar-2024 11:05 AM EST
Iron Restriction Keeps Blood Stem Cells Young
Albert Einstein College of Medicine

As we age, our hematopoietic (blood-forming) stem cells (HSCs) become less able to produce new red and white blood cells and other vital blood components—contributing to chronic inflammation and accelerating the onset of blood cancers and degenerative diseases.

Newswise: IU researcher developing new pediatric leukemia therapies
Released: 8-Mar-2024 10:05 AM EST
IU researcher developing new pediatric leukemia therapies
Indiana University

Reuben Kapur, director of the Herman B Wells Center for Pediatric Research at the Indiana University School of Medicine, is working to discover new treatments that will improve patient care.

Newswise: Children’s Hospital Los Angeles Awarded $6 Million from CIRM to Advance CAR T-Cell Therapies in Children with Recurring Solid Tumors
Released: 29-Feb-2024 6:05 PM EST
Children’s Hospital Los Angeles Awarded $6 Million from CIRM to Advance CAR T-Cell Therapies in Children with Recurring Solid Tumors
Children's Hospital Los Angeles

Children’s Hospital Los Angeles has received a multi-year $6 million award from the California Institute for Regenerative Medicine (CIRM) to develop innovative stem cell approaches to treat children and adolescents with recurrent solid tumors. The Cancer and Blood Disease Institute (CBDI) is a recognized leader in pediatric cancer care and research.

Newswise: ‘Gene of Prejudice’ Demystifies Autism
Released: 28-Feb-2024 4:00 PM EST
‘Gene of Prejudice’ Demystifies Autism
University of California San Diego

Individuals with Williams syndrome have a gregarious “cocktail party” personality, while those with the opposite genetic alteration, in contrast, tend to have autistic traits and are prone to struggle socially. Research from UC San Diego sheds new light on the gene responsible.

Released: 26-Feb-2024 2:05 PM EST
UC Irvine advances stem cell research with $4 million CIRM grant for shared resources lab
University of California, Irvine

Irvine, Calif., Feb. 26, 2024 — The University of California, Irvine has received a five-year, $4 million grant from the California Institute for Regenerative Medicine to establish a shared resources lab in the Sue & Bill Gross Stem Cell Research Center. The facility will offer essential technologies and training for the development of novel in vitro stem cell-based modeling that will serve researchers across the campus and the state.

Released: 26-Feb-2024 12:00 PM EST
Recent progress in hair follicle stem cell markers and their regulatory roles
World Journal of Stem Cells

Hair follicle stem cells (HFSCs) in the bulge are a multipotent adult stem cell population. They can periodically give rise to new HFs and even regenerate the epidermis and sebaceous glands during wound healing. An increasing number of biom

Released: 26-Feb-2024 12:00 PM EST
Multiple pretreatments can effectively improve the functionality of mesenchymal stem cells
World Journal of Stem Cells

In this editorial, we offer our perspective on the groundbreaking study entitled “Hypoxia and inflammatory factor preconditioning enhances the immunosuppressive properties of human umbilical cord mesenchymal stem cells”, recently publis

Released: 26-Feb-2024 12:00 PM EST
Advances in the differentiation of pluripotent stem cells into vascular cells
World Journal of Stem Cells

Blood vessels constitute a closed pipe system distributed throughout the body, transporting blood from the heart to other organs and delivering metabolic waste products back to the lungs and kidneys. Changes in blood vessels are related to

Released: 26-Feb-2024 12:00 PM EST
VX-509 attenuates the stemness characteristics of colorectal cancer stem-like cells by regulating the epithelial-mesenchymal transition through Nodal/Smad2/3 signaling
World Journal of Stem Cells

BACKGROUNDColorectal cancer stem cells (CCSCs) are heterogeneous cells that can self-renew and undergo multidirectional differentiation in colorectal cancer (CRC) patients. CCSCs are generally accepted to be important sources of CRC and are

Released: 26-Feb-2024 12:00 PM EST
Crosstalk between Wnt and bone morphogenetic protein signaling during osteogenic differentiation
World Journal of Stem Cells

Mesenchymal stem cells (MSCs) originate from many sources, including the bone marrow and adipose tissue, and differentiate into various cell types, such as osteoblasts and adipocytes. Recent studies on MSCs have revealed that many transcrip

Released: 26-Feb-2024 12:00 PM EST
Silencing of Jumonji domain-containing 1C inhibits the osteogenic differentiation of bone marrow mesenchymal stem cells via nuclear factor-κB signaling
World Journal of Stem Cells

BACKGROUNDOsteoporosis is a common metabolic bone disorder induced by an imbalance between osteoclastic activity and osteogenic activity. During osteoporosis, bone mesenchymal stem cells (BMSCs) exhibit an increased ability to differentiate

Released: 26-Feb-2024 12:00 PM EST
Therapeutic utility of human umbilical cord-derived mesenchymal stem cells-based approaches in pulmonary diseases: Recent advancements and prospects
World Journal of Stem Cells

Pulmonary diseases across all ages threaten millions of people and have emerged as one of the major public health issues worldwide. For diverse disease conditions, the currently available approaches are focused on alleviating clinical sympt

Released: 26-Feb-2024 12:00 PM EST
Cellular preconditioning and mesenchymal stem cell ferroptosis
World Journal of Stem Cells

In this editorial, we comment on the article published in the recent issue of the World Journal of Stem Cells. They focus on stem cell preconditioning to prevent ferroptosis by modulating the cystathionine γ-lyase/hydrogen sulfide (H2S) pa

Released: 26-Feb-2024 12:00 PM EST
Human dental pulp stem/stromal cells in clinical practice
World Journal of Stem Cells

Dental pulp stem/stromal cells (DPSCs) are fibroblast-like, neural crest-derived, and multipotent cells that can differentiate into several lineages. They are relatively easy to isolate from healthy and inflamed pulps, with little ethical c



close
1.7495